Teriparatid-Mepha
Teriparatid-Mepha is a medicine authorised by Swissmedic under authorisation number 66102. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 November 2017 and the authorisation is valid without a time limit. ATC code H05AA02 places the medicine in the group Calcium homeostasis.
| Authorisation number | 66102 |
|---|---|
| Name | Teriparatid-Mepha |
| Full name | Teriparatid-Mepha, Injektionslösung im Fertigpen |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | H05AA02 |
| First authorisation | 17 November 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Teriparatid-Mepha, Injektionslösung im Fertigpen | B | 17 November 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Injektor(en), vorgefüllt/Pen | H05AA02 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Teriparatid-Mepha authorised in Switzerland?
Yes. Teriparatid-Mepha is authorised by Swissmedic under authorisation number 66102, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Teriparatid-Mepha have?
Teriparatid-Mepha is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Teriparatid-Mepha?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.